Abstract
Neuraminidase (NA) is the major surface glycoprotein of the influenza virus. It has been considered a suitable target for designing agents against influenza viruses. Rational drug design of NA inhibitors is now in the clinic and is effective for the treatment of influenza. Recently, research of structure-based NA inhibitors is becoming an interesting field, leading to a breakthrough in the control of influenza. Here we review a series of neuraminidase inhibitors and the recent progress in this field.
| Original language | English |
|---|---|
| Pages (from-to) | 429-448 |
| Number of pages | 20 |
| Journal | Mini-Reviews in Medicinal Chemistry |
| Volume | 6 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2006 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Advances
- Anti-influenza agents
- Antiviral
- Influenza
- Influenza virus
- Neuraminidase (NA)
- Neuraminidase inhibitors (NAIs)
- Sialic acid (SA)
Fingerprint
Dive into the research topics of 'Recent advances in anti-influenza agents with neuraminidase as target'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver